Glycosaminoglycans During Septic Shock - a Temporal Study (GAGS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00814112
Recruitment Status : Unknown
Verified October 2009 by Region Skane.
Recruitment status was:  Recruiting
First Posted : December 23, 2008
Last Update Posted : October 8, 2009
Information provided by:
Region Skane

Brief Summary:
We have previously shown that the plasma level of glycosaminoglycans (GAG) in septic shock patients are elevated compared to controls. The purpose of this study is to investigate the temporal dynamic of the blood level of GAG in ten septic shock patients. In addition, to assess the kinetics of GAG during septic shock we examine the liver function by galactose elimination capacity as well as excreted urinary GAG.

Condition or disease
Septic Shock

Study Type : Observational
Estimated Enrollment : 20 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: GAGS - Glykosaminoglykaner Vid Sepsis
Study Start Date : November 2008
Estimated Primary Completion Date : November 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Shock
U.S. FDA Resources

1 septic shock
septic shock, ICU
2 controls
matched controls

Biospecimen Retention:   Samples Without DNA
Plasma and Urine.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Septic Shock

Inclusion Criteria:

  • 2 out of 4 SIRS criteria, where the circulatory criteria must be fulfilled
  • Clinical sepsis is suspected
  • Informed consent from relative
  • Study subject must be over 18 years old

Exclusion Criteria:

  • Pregnancy
  • >24h post sepsis diagnosis
  • Ongoing oral or intravenous cortisone treatment for more than one month.
  • Malignancy with metastasis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00814112

Contact: Ingrid Berkestedt, MD PhD +4646171949
Contact: Axel Nelson, PhD-student

Intensive Care Unit, Lund University Hospital Recruiting
Lund, Sweden, 22185
Contact: Ingrid Berkestedt, MD PhD    +4646171949   
Sub-Investigator: Axel Nelson, PhD student         
Sub-Investigator: Ingrid Berkestedt, MD PhD         
Sponsors and Collaborators
Region Skane
Principal Investigator: Mikael Bodelsson, professor Intensive Care Unit, Lund University Hospital, Sweden

Responsible Party: Mikael Bodelsson/Professor, Lund University Hospital Identifier: NCT00814112     History of Changes
Other Study ID Numbers: GAGS 293/2008
First Posted: December 23, 2008    Key Record Dates
Last Update Posted: October 8, 2009
Last Verified: October 2009

Additional relevant MeSH terms:
Shock, Septic
Pathologic Processes
Systemic Inflammatory Response Syndrome